nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunisolide—CYP3A4—Topotecan—lung cancer	0.0713	0.142	CbGbCtD
Flunisolide—CYP3A4—Gefitinib—lung cancer	0.0652	0.13	CbGbCtD
Flunisolide—CYP3A4—Teniposide—lung cancer	0.0632	0.126	CbGbCtD
Flunisolide—CYP3A4—Vinorelbine—lung cancer	0.0502	0.1	CbGbCtD
Flunisolide—CYP3A4—Crizotinib—lung cancer	0.0399	0.0796	CbGbCtD
Flunisolide—CYP3A4—Erlotinib—lung cancer	0.0385	0.0768	CbGbCtD
Flunisolide—CYP3A4—Paclitaxel—lung cancer	0.0353	0.0703	CbGbCtD
Flunisolide—CYP3A4—Irinotecan—lung cancer	0.0348	0.0694	CbGbCtD
Flunisolide—CYP3A4—Vinblastine—lung cancer	0.0309	0.0617	CbGbCtD
Flunisolide—CYP3A4—Etoposide—lung cancer	0.0279	0.0556	CbGbCtD
Flunisolide—CYP3A4—Docetaxel—lung cancer	0.0255	0.0508	CbGbCtD
Flunisolide—CYP3A4—Doxorubicin—lung cancer	0.019	0.0379	CbGbCtD
Flunisolide—Amcinonide—ANXA1—lung cancer	0.00353	0.323	CrCbGaD
Flunisolide—Hydrocortisone—ANXA1—lung cancer	0.00149	0.136	CrCbGaD
Flunisolide—NR3C1—Nuclear Receptors—RARB—lung cancer	0.00112	0.0169	CbGpPWpGaD
Flunisolide—Dexamethasone—ANXA1—lung cancer	0.00111	0.102	CrCbGaD
Flunisolide—NR3C1—Endoderm Differentiation—NKX2-1—lung cancer	0.00106	0.0161	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—NODAL—lung cancer	0.000903	0.0137	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP2A7—lung cancer	0.000893	0.0135	CbGpPWpGaD
Flunisolide—NR3C1—Nuclear Receptor transcription pathway—RARB—lung cancer	0.000884	0.0134	CbGpPWpGaD
Flunisolide—CYP3A4—Irinotecan Pathway—UGT1A1—lung cancer	0.000846	0.0128	CbGpPWpGaD
Flunisolide—CYP3A4—Aflatoxin B1 metabolism—GSTM1—lung cancer	0.000774	0.0117	CbGpPWpGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC3—lung cancer	0.000771	0.0117	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—SKI—lung cancer	0.000761	0.0115	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—GSTA1—lung cancer	0.000744	0.0113	CbGpPWpGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—BRAF—lung cancer	0.000734	0.0111	CbGpPWpGaD
Flunisolide—CYP3A4—Irinotecan Pathway—ABCG2—lung cancer	0.000734	0.0111	CbGpPWpGaD
Flunisolide—CYP3A4—Codeine and Morphine Metabolism—ABCB1—lung cancer	0.000717	0.0109	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—UGT1A1—lung cancer	0.000692	0.0105	CbGpPWpGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAP2K1—lung cancer	0.000691	0.0105	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—SOX2—lung cancer	0.000685	0.0104	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—NPPA—lung cancer	0.000669	0.0101	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—lung cancer	0.000656	0.00994	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—ATF3—lung cancer	0.000633	0.00959	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP2A6—lung cancer	0.00062	0.00939	CbGpPWpGaD
Flunisolide—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—lung cancer	0.0006	0.00909	CbGpPWpGaD
Flunisolide—Prednisolone—CYP2A6—lung cancer	0.000598	0.0547	CrCbGaD
Flunisolide—NR3C1—Endoderm Differentiation—PTHLH—lung cancer	0.000582	0.00882	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—HSD17B10—lung cancer	0.00058	0.00879	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—SFN—lung cancer	0.000571	0.00865	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—ATF3—lung cancer	0.000564	0.00854	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—lung cancer	0.000527	0.00798	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—SMARCA4—lung cancer	0.000525	0.00796	CbGpPWpGaD
Flunisolide—NR3C1—Endoderm Differentiation—APP—lung cancer	0.000519	0.00786	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP2A6—lung cancer	0.000519	0.00786	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CHRNB4—lung cancer	0.0005	0.00757	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP2A6—lung cancer	0.000499	0.00755	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IRF1—lung cancer	0.00049	0.00743	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—lung cancer	0.000487	0.00738	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—JUNB—lung cancer	0.00048	0.00727	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—AVP—lung cancer	0.000478	0.00724	CbGpPWpGaD
Flunisolide—CYP3A4—Estrogen metabolism—NQO1—lung cancer	0.000474	0.00719	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC3—lung cancer	0.000465	0.00704	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC3—lung cancer	0.000443	0.0067	CbGpPWpGaD
Flunisolide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK3—lung cancer	0.000442	0.00669	CbGpPWpGaD
Flunisolide—CYP3A4—Xenobiotics—CYP2E1—lung cancer	0.000441	0.00668	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—APOA1—lung cancer	0.000437	0.00662	CbGpPWpGaD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—UGT1A1—lung cancer	0.000437	0.00662	CbGpPWpGaD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—CREBBP—lung cancer	0.000425	0.00644	CbGpPWpGaD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP2E1—lung cancer	0.000424	0.00642	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—AHR—lung cancer	0.000418	0.00634	CbGpPWpGaD
Flunisolide—Hydrocortisone—ABCG2—lung cancer	0.000409	0.0374	CrCbGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—lung cancer	0.000405	0.00613	CbGpPWpGaD
Flunisolide—Fluticasone furoate—ABCB1—lung cancer	0.000396	0.0362	CrCbGaD
Flunisolide—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—lung cancer	0.000392	0.00594	CbGpPWpGaD
Flunisolide—Constipation—Irinotecan—lung cancer	0.000386	0.000916	CcSEcCtD
Flunisolide—Pain—Irinotecan—lung cancer	0.000386	0.000916	CcSEcCtD
Flunisolide—Myalgia—Paclitaxel—lung cancer	0.000384	0.000911	CcSEcCtD
Flunisolide—Chest pain—Paclitaxel—lung cancer	0.000384	0.000911	CcSEcCtD
Flunisolide—Anxiety—Paclitaxel—lung cancer	0.000383	0.000908	CcSEcCtD
Flunisolide—Malnutrition—Docetaxel—lung cancer	0.000382	0.000907	CcSEcCtD
Flunisolide—Decreased appetite—Gemcitabine—lung cancer	0.000382	0.000907	CcSEcCtD
Flunisolide—Nausea—Topotecan—lung cancer	0.00038	0.000902	CcSEcCtD
Flunisolide—Discomfort—Paclitaxel—lung cancer	0.000379	0.0009	CcSEcCtD
Flunisolide—Abdominal discomfort—Methotrexate—lung cancer	0.000379	0.0009	CcSEcCtD
Flunisolide—Fatigue—Gemcitabine—lung cancer	0.000379	0.0009	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—FOXM1—lung cancer	0.000379	0.00574	CbGpPWpGaD
Flunisolide—NR3C1—Circadian Clock—HIF1A—lung cancer	0.000379	0.00574	CbGpPWpGaD
Flunisolide—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—lung cancer	0.000379	0.00574	CbGpPWpGaD
Flunisolide—Constipation—Gemcitabine—lung cancer	0.000376	0.000892	CcSEcCtD
Flunisolide—Pain—Gemcitabine—lung cancer	0.000376	0.000892	CcSEcCtD
Flunisolide—Nausea—Erlotinib—lung cancer	0.000376	0.000892	CcSEcCtD
Flunisolide—Diarrhoea—Vinorelbine—lung cancer	0.000374	0.000889	CcSEcCtD
Flunisolide—Dysgeusia—Docetaxel—lung cancer	0.000374	0.000888	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—FOXO3—lung cancer	0.000374	0.00567	CbGpPWpGaD
Flunisolide—Musculoskeletal discomfort—Cisplatin—lung cancer	0.000373	0.000886	CcSEcCtD
Flunisolide—Infection—Etoposide—lung cancer	0.000373	0.000885	CcSEcCtD
Flunisolide—Feeling abnormal—Irinotecan—lung cancer	0.000372	0.000883	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A7—lung cancer	0.000371	0.00562	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL10—lung cancer	0.000371	0.00561	CbGpPWpGaD
Flunisolide—Back pain—Docetaxel—lung cancer	0.00037	0.000878	CcSEcCtD
Flunisolide—Gastrointestinal pain—Irinotecan—lung cancer	0.000369	0.000876	CcSEcCtD
Flunisolide—Oedema—Paclitaxel—lung cancer	0.000368	0.000874	CcSEcCtD
Flunisolide—Upper respiratory tract infection—Methotrexate—lung cancer	0.000367	0.000872	CcSEcCtD
Flunisolide—Tachycardia—Etoposide—lung cancer	0.000366	0.00087	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP2A7—lung cancer	0.000366	0.00554	CbGpPWpGaD
Flunisolide—Infection—Paclitaxel—lung cancer	0.000366	0.000868	CcSEcCtD
Flunisolide—Dyspnoea—Cisplatin—lung cancer	0.000365	0.000867	CcSEcCtD
Flunisolide—CYP3A4—Estrogen metabolism—GSTM1—lung cancer	0.000364	0.00551	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Etoposide—lung cancer	0.000363	0.000861	CcSEcCtD
Flunisolide—Feeling abnormal—Gemcitabine—lung cancer	0.000362	0.00086	CcSEcCtD
Flunisolide—Shock—Paclitaxel—lung cancer	0.000362	0.000859	CcSEcCtD
Flunisolide—Dizziness—Vinorelbine—lung cancer	0.000362	0.000859	CcSEcCtD
Flunisolide—Tachycardia—Paclitaxel—lung cancer	0.000359	0.000853	CcSEcCtD
Flunisolide—Body temperature increased—Irinotecan—lung cancer	0.000357	0.000847	CcSEcCtD
Flunisolide—Abdominal pain—Irinotecan—lung cancer	0.000357	0.000847	CcSEcCtD
Flunisolide—Decreased appetite—Cisplatin—lung cancer	0.000356	0.000845	CcSEcCtD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2A6—lung cancer	0.000356	0.00539	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Paclitaxel—lung cancer	0.000356	0.000845	CcSEcCtD
Flunisolide—Pneumonia—Methotrexate—lung cancer	0.000355	0.000842	CcSEcCtD
Flunisolide—Nasopharyngitis—Doxorubicin—lung cancer	0.000354	0.000841	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—SOX2—lung cancer	0.000352	0.00534	CbGpPWpGaD
Flunisolide—Pain—Cisplatin—lung cancer	0.00035	0.000832	CcSEcCtD
Flunisolide—Vomiting—Vinorelbine—lung cancer	0.000348	0.000826	CcSEcCtD
Flunisolide—Body temperature increased—Gemcitabine—lung cancer	0.000348	0.000825	CcSEcCtD
Flunisolide—NR3C1—Adipogenesis—LMNA—lung cancer	0.000347	0.00525	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—lung cancer	0.000346	0.00524	CbGpPWpGaD
Flunisolide—Rash—Vinorelbine—lung cancer	0.000345	0.000819	CcSEcCtD
Flunisolide—Dermatitis—Vinorelbine—lung cancer	0.000345	0.000818	CcSEcCtD
Flunisolide—CYP3A4—Estrogen metabolism—CYP1A1—lung cancer	0.000345	0.00522	CbGpPWpGaD
Flunisolide—Abdominal distension—Doxorubicin—lung cancer	0.000345	0.000818	CcSEcCtD
Flunisolide—Stomatitis—Methotrexate—lung cancer	0.000344	0.000816	CcSEcCtD
Flunisolide—Headache—Vinorelbine—lung cancer	0.000343	0.000814	CcSEcCtD
Flunisolide—Syncope—Docetaxel—lung cancer	0.000343	0.000814	CcSEcCtD
Flunisolide—Conjunctivitis—Methotrexate—lung cancer	0.000343	0.000813	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—ALDOA—lung cancer	0.000341	0.00517	CbGpPWpGaD
Flunisolide—Dexamethasone—CYP2A6—lung cancer	0.000341	0.0312	CrCbGaD
Flunisolide—Sweating—Methotrexate—lung cancer	0.000338	0.000802	CcSEcCtD
Flunisolide—Palpitations—Docetaxel—lung cancer	0.000338	0.000802	CcSEcCtD
Flunisolide—Feeling abnormal—Cisplatin—lung cancer	0.000338	0.000801	CcSEcCtD
Flunisolide—Loss of consciousness—Docetaxel—lung cancer	0.000336	0.000797	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000335	0.000796	CcSEcCtD
Flunisolide—Dyspnoea—Etoposide—lung cancer	0.000335	0.000794	CcSEcCtD
Flunisolide—Cough—Docetaxel—lung cancer	0.000334	0.000792	CcSEcCtD
Flunisolide—Insomnia—Paclitaxel—lung cancer	0.000333	0.00079	CcSEcCtD
Flunisolide—Epistaxis—Methotrexate—lung cancer	0.000333	0.000789	CcSEcCtD
Flunisolide—Hypersensitivity—Irinotecan—lung cancer	0.000332	0.000789	CcSEcCtD
Flunisolide—CYP3A4—Irinotecan Pathway—APC—lung cancer	0.00033	0.005	CbGpPWpGaD
Flunisolide—Hypertension—Docetaxel—lung cancer	0.00033	0.000783	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—lung cancer	0.00033	0.005	CbGpPWpGaD
Flunisolide—Bronchitis—Doxorubicin—lung cancer	0.000329	0.000782	CcSEcCtD
Flunisolide—Dyspnoea—Paclitaxel—lung cancer	0.000328	0.000779	CcSEcCtD
Flunisolide—Decreased appetite—Etoposide—lung cancer	0.000326	0.000775	CcSEcCtD
Flunisolide—Myalgia—Docetaxel—lung cancer	0.000325	0.000772	CcSEcCtD
Flunisolide—Chest pain—Docetaxel—lung cancer	0.000325	0.000772	CcSEcCtD
Flunisolide—Nausea—Vinorelbine—lung cancer	0.000325	0.000771	CcSEcCtD
Flunisolide—Dyspepsia—Paclitaxel—lung cancer	0.000324	0.000769	CcSEcCtD
Flunisolide—Body temperature increased—Cisplatin—lung cancer	0.000324	0.000769	CcSEcCtD
Flunisolide—Asthenia—Irinotecan—lung cancer	0.000324	0.000769	CcSEcCtD
Flunisolide—Fatigue—Etoposide—lung cancer	0.000324	0.000768	CcSEcCtD
Flunisolide—Pain—Etoposide—lung cancer	0.000321	0.000762	CcSEcCtD
Flunisolide—Constipation—Etoposide—lung cancer	0.000321	0.000762	CcSEcCtD
Flunisolide—Decreased appetite—Paclitaxel—lung cancer	0.00032	0.000759	CcSEcCtD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—CREBBP—lung cancer	0.000319	0.00483	CbGpPWpGaD
Flunisolide—Upper respiratory tract infection—Doxorubicin—lung cancer	0.000318	0.000755	CcSEcCtD
Flunisolide—Fatigue—Paclitaxel—lung cancer	0.000317	0.000753	CcSEcCtD
Flunisolide—CYP3A4—Xenobiotics—CYP1A1—lung cancer	0.000317	0.0048	CbGpPWpGaD
Flunisolide—Methylprednisolone—ABCB1—lung cancer	0.000316	0.0289	CrCbGaD
Flunisolide—Asthenia—Gemcitabine—lung cancer	0.000315	0.000749	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP1—lung cancer	0.000315	0.00477	CbGpPWpGaD
Flunisolide—Pain—Paclitaxel—lung cancer	0.000315	0.000747	CcSEcCtD
Flunisolide—Constipation—Paclitaxel—lung cancer	0.000315	0.000747	CcSEcCtD
Flunisolide—Pharyngitis—Methotrexate—lung cancer	0.000314	0.000746	CcSEcCtD
Flunisolide—Triamcinolone—PTGS2—lung cancer	0.000313	0.0286	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—HIF1A—lung cancer	0.000312	0.00473	CbGpPWpGaD
Flunisolide—Oedema—Docetaxel—lung cancer	0.000312	0.00074	CcSEcCtD
Flunisolide—Weight increased—Doxorubicin—lung cancer	0.000312	0.00074	CcSEcCtD
Flunisolide—Pruritus—Gemcitabine—lung cancer	0.000311	0.000738	CcSEcCtD
Flunisolide—Infection—Docetaxel—lung cancer	0.00031	0.000736	CcSEcCtD
Flunisolide—NR3C1—Circadian Clock—CREBBP—lung cancer	0.000309	0.00469	CbGpPWpGaD
Flunisolide—Feeling abnormal—Etoposide—lung cancer	0.000309	0.000734	CcSEcCtD
Flunisolide—Diarrhoea—Irinotecan—lung cancer	0.000309	0.000733	CcSEcCtD
Flunisolide—Pneumonia—Doxorubicin—lung cancer	0.000307	0.000729	CcSEcCtD
Flunisolide—Gastrointestinal pain—Etoposide—lung cancer	0.000307	0.000729	CcSEcCtD
Flunisolide—Shock—Docetaxel—lung cancer	0.000307	0.000728	CcSEcCtD
Flunisolide—CYP3A4—Tamoxifen metabolism—CYP1A1—lung cancer	0.000305	0.00461	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCG2—lung cancer	0.000305	0.0279	CrCbGaD
Flunisolide—Tachycardia—Docetaxel—lung cancer	0.000304	0.000723	CcSEcCtD
Flunisolide—Feeling abnormal—Paclitaxel—lung cancer	0.000303	0.00072	CcSEcCtD
Flunisolide—Hypersensitivity—Cisplatin—lung cancer	0.000302	0.000717	CcSEcCtD
Flunisolide—Gastrointestinal pain—Paclitaxel—lung cancer	0.000301	0.000714	CcSEcCtD
Flunisolide—Diarrhoea—Gemcitabine—lung cancer	0.000301	0.000714	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A7—lung cancer	0.000301	0.00455	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—TF—lung cancer	0.0003	0.00454	CbGpPWpGaD
Flunisolide—Erythema multiforme—Methotrexate—lung cancer	0.000299	0.00071	CcSEcCtD
Flunisolide—Dizziness—Irinotecan—lung cancer	0.000298	0.000708	CcSEcCtD
Flunisolide—Urticaria—Etoposide—lung cancer	0.000298	0.000708	CcSEcCtD
Flunisolide—Stomatitis—Doxorubicin—lung cancer	0.000298	0.000706	CcSEcCtD
Flunisolide—Body temperature increased—Etoposide—lung cancer	0.000297	0.000704	CcSEcCtD
Flunisolide—Abdominal pain—Etoposide—lung cancer	0.000297	0.000704	CcSEcCtD
Flunisolide—Urinary tract infection—Doxorubicin—lung cancer	0.000297	0.000704	CcSEcCtD
Flunisolide—Conjunctivitis—Doxorubicin—lung cancer	0.000297	0.000704	CcSEcCtD
Flunisolide—Asthenia—Cisplatin—lung cancer	0.000294	0.000698	CcSEcCtD
Flunisolide—Sweating—Doxorubicin—lung cancer	0.000293	0.000695	CcSEcCtD
Flunisolide—Urticaria—Paclitaxel—lung cancer	0.000292	0.000694	CcSEcCtD
Flunisolide—Body temperature increased—Paclitaxel—lung cancer	0.000291	0.000691	CcSEcCtD
Flunisolide—Abdominal pain—Paclitaxel—lung cancer	0.000291	0.000691	CcSEcCtD
Flunisolide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—lung cancer	0.000289	0.00438	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—lung cancer	0.000288	0.00437	CbGpPWpGaD
Flunisolide—Epistaxis—Doxorubicin—lung cancer	0.000288	0.000683	CcSEcCtD
Flunisolide—NR3C1—Transcription factor regulation in adipogenesis—IL6—lung cancer	0.000287	0.00435	CbGpPWpGaD
Flunisolide—Vomiting—Irinotecan—lung cancer	0.000287	0.000681	CcSEcCtD
Flunisolide—Sinusitis—Doxorubicin—lung cancer	0.000286	0.00068	CcSEcCtD
Flunisolide—Rash—Irinotecan—lung cancer	0.000285	0.000675	CcSEcCtD
Flunisolide—Dermatitis—Irinotecan—lung cancer	0.000284	0.000675	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000284	0.000675	CcSEcCtD
Flunisolide—Chills—Methotrexate—lung cancer	0.000284	0.000674	CcSEcCtD
Flunisolide—Headache—Irinotecan—lung cancer	0.000283	0.000671	CcSEcCtD
Flunisolide—Insomnia—Docetaxel—lung cancer	0.000282	0.00067	CcSEcCtD
Flunisolide—NR3C1—Endoderm Differentiation—APC—lung cancer	0.000282	0.00427	CbGpPWpGaD
Flunisolide—Diarrhoea—Cisplatin—lung cancer	0.00028	0.000665	CcSEcCtD
Flunisolide—Vomiting—Gemcitabine—lung cancer	0.00028	0.000663	CcSEcCtD
Flunisolide—Dyspnoea—Docetaxel—lung cancer	0.000278	0.00066	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MMP1—lung cancer	0.000278	0.00421	CbGpPWpGaD
Flunisolide—Rash—Gemcitabine—lung cancer	0.000277	0.000658	CcSEcCtD
Flunisolide—Dermatitis—Gemcitabine—lung cancer	0.000277	0.000657	CcSEcCtD
Flunisolide—Hypersensitivity—Etoposide—lung cancer	0.000277	0.000656	CcSEcCtD
Flunisolide—Malnutrition—Methotrexate—lung cancer	0.000275	0.000654	CcSEcCtD
Flunisolide—Headache—Gemcitabine—lung cancer	0.000275	0.000654	CcSEcCtD
Flunisolide—Rhinitis—Doxorubicin—lung cancer	0.000275	0.000652	CcSEcCtD
Flunisolide—Dyspepsia—Docetaxel—lung cancer	0.000275	0.000652	CcSEcCtD
Flunisolide—Hypoaesthesia—Doxorubicin—lung cancer	0.000273	0.000647	CcSEcCtD
Flunisolide—Pharyngitis—Doxorubicin—lung cancer	0.000272	0.000646	CcSEcCtD
Flunisolide—Decreased appetite—Docetaxel—lung cancer	0.000271	0.000644	CcSEcCtD
Flunisolide—Hypersensitivity—Paclitaxel—lung cancer	0.000271	0.000644	CcSEcCtD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—MDM2—lung cancer	0.000271	0.0041	CbGpPWpGaD
Flunisolide—Oedema peripheral—Doxorubicin—lung cancer	0.00027	0.000641	CcSEcCtD
Flunisolide—Dysgeusia—Methotrexate—lung cancer	0.00027	0.00064	CcSEcCtD
Flunisolide—Asthenia—Etoposide—lung cancer	0.000269	0.000639	CcSEcCtD
Flunisolide—Fatigue—Docetaxel—lung cancer	0.000269	0.000638	CcSEcCtD
Flunisolide—Nausea—Irinotecan—lung cancer	0.000268	0.000636	CcSEcCtD
Flunisolide—Constipation—Docetaxel—lung cancer	0.000267	0.000633	CcSEcCtD
Flunisolide—Pain—Docetaxel—lung cancer	0.000267	0.000633	CcSEcCtD
Flunisolide—Back pain—Methotrexate—lung cancer	0.000266	0.000633	CcSEcCtD
Flunisolide—Pruritus—Etoposide—lung cancer	0.000266	0.00063	CcSEcCtD
Flunisolide—Asthenia—Paclitaxel—lung cancer	0.000264	0.000627	CcSEcCtD
Flunisolide—Nausea—Gemcitabine—lung cancer	0.000261	0.00062	CcSEcCtD
Flunisolide—Vomiting—Cisplatin—lung cancer	0.000261	0.000618	CcSEcCtD
Flunisolide—Pruritus—Paclitaxel—lung cancer	0.00026	0.000618	CcSEcCtD
Flunisolide—Vision blurred—Methotrexate—lung cancer	0.00026	0.000616	CcSEcCtD
Flunisolide—Erythema multiforme—Doxorubicin—lung cancer	0.000259	0.000615	CcSEcCtD
Flunisolide—Rash—Cisplatin—lung cancer	0.000258	0.000613	CcSEcCtD
Flunisolide—Dermatitis—Cisplatin—lung cancer	0.000258	0.000613	CcSEcCtD
Flunisolide—Feeling abnormal—Docetaxel—lung cancer	0.000257	0.00061	CcSEcCtD
Flunisolide—Diarrhoea—Etoposide—lung cancer	0.000257	0.00061	CcSEcCtD
Flunisolide—Betamethasone—PTGS2—lung cancer	0.000256	0.0235	CrCbGaD
Flunisolide—Ill-defined disorder—Methotrexate—lung cancer	0.000256	0.000607	CcSEcCtD
Flunisolide—Gastrointestinal pain—Docetaxel—lung cancer	0.000255	0.000605	CcSEcCtD
Flunisolide—Prednisone—ALB—lung cancer	0.000253	0.0231	CrCbGaD
Flunisolide—Diarrhoea—Paclitaxel—lung cancer	0.000252	0.000598	CcSEcCtD
Flunisolide—Malaise—Methotrexate—lung cancer	0.000248	0.00059	CcSEcCtD
Flunisolide—Dizziness—Etoposide—lung cancer	0.000248	0.000589	CcSEcCtD
Flunisolide—Vertigo—Methotrexate—lung cancer	0.000248	0.000587	CcSEcCtD
Flunisolide—Abdominal pain—Docetaxel—lung cancer	0.000247	0.000585	CcSEcCtD
Flunisolide—Body temperature increased—Docetaxel—lung cancer	0.000247	0.000585	CcSEcCtD
Flunisolide—Chills—Doxorubicin—lung cancer	0.000246	0.000584	CcSEcCtD
Flunisolide—Dizziness—Paclitaxel—lung cancer	0.000243	0.000578	CcSEcCtD
Flunisolide—Nausea—Cisplatin—lung cancer	0.000243	0.000578	CcSEcCtD
Flunisolide—Dexamethasone—CYP2E1—lung cancer	0.000242	0.0221	CrCbGaD
Flunisolide—Prednisone—ABCB1—lung cancer	0.000241	0.0221	CrCbGaD
Flunisolide—Cough—Methotrexate—lung cancer	0.00024	0.000571	CcSEcCtD
Flunisolide—Vomiting—Etoposide—lung cancer	0.000239	0.000566	CcSEcCtD
Flunisolide—Malnutrition—Doxorubicin—lung cancer	0.000239	0.000566	CcSEcCtD
Flunisolide—Dexamethasone—CYP1A1—lung cancer	0.000239	0.0218	CrCbGaD
Flunisolide—Rash—Etoposide—lung cancer	0.000237	0.000562	CcSEcCtD
Flunisolide—Dermatitis—Etoposide—lung cancer	0.000236	0.000561	CcSEcCtD
Flunisolide—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—lung cancer	0.000236	0.00358	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—JUN—lung cancer	0.000235	0.00356	CbGpPWpGaD
Flunisolide—Headache—Etoposide—lung cancer	0.000235	0.000558	CcSEcCtD
Flunisolide—Myalgia—Methotrexate—lung cancer	0.000235	0.000557	CcSEcCtD
Flunisolide—Chest pain—Methotrexate—lung cancer	0.000235	0.000557	CcSEcCtD
Flunisolide—Vomiting—Paclitaxel—lung cancer	0.000234	0.000555	CcSEcCtD
Flunisolide—Dysgeusia—Doxorubicin—lung cancer	0.000234	0.000554	CcSEcCtD
Flunisolide—Rash—Paclitaxel—lung cancer	0.000232	0.000551	CcSEcCtD
Flunisolide—Dermatitis—Paclitaxel—lung cancer	0.000232	0.00055	CcSEcCtD
Flunisolide—Discomfort—Methotrexate—lung cancer	0.000232	0.00055	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—POMC—lung cancer	0.000231	0.0035	CbGpPWpGaD
Flunisolide—Back pain—Doxorubicin—lung cancer	0.000231	0.000548	CcSEcCtD
Flunisolide—Headache—Paclitaxel—lung cancer	0.000231	0.000547	CcSEcCtD
Flunisolide—Hypersensitivity—Docetaxel—lung cancer	0.00023	0.000546	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CREBBP—lung cancer	0.000227	0.00344	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP2E1—lung cancer	0.000226	0.00343	CbGpPWpGaD
Flunisolide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—lung cancer	0.000225	0.00341	CbGpPWpGaD
Flunisolide—Vision blurred—Doxorubicin—lung cancer	0.000225	0.000534	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CREBBP—lung cancer	0.000225	0.00341	CbGpPWpGaD
Flunisolide—Asthenia—Docetaxel—lung cancer	0.000224	0.000531	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—CDKN2A—lung cancer	0.000223	0.00338	CbGpPWpGaD
Flunisolide—Infection—Methotrexate—lung cancer	0.000223	0.00053	CcSEcCtD
Flunisolide—Nausea—Etoposide—lung cancer	0.000223	0.000529	CcSEcCtD
Flunisolide—Prednisolone—ABCB1—lung cancer	0.000222	0.0204	CrCbGaD
Flunisolide—Ill-defined disorder—Doxorubicin—lung cancer	0.000221	0.000525	CcSEcCtD
Flunisolide—Pruritus—Docetaxel—lung cancer	0.000221	0.000524	CcSEcCtD
Flunisolide—Agitation—Doxorubicin—lung cancer	0.000219	0.00052	CcSEcCtD
Flunisolide—Nausea—Paclitaxel—lung cancer	0.000219	0.000519	CcSEcCtD
Flunisolide—Betamethasone—ABCB1—lung cancer	0.000218	0.0199	CrCbGaD
Flunisolide—Hyperhidrosis—Methotrexate—lung cancer	0.000217	0.000516	CcSEcCtD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—EP300—lung cancer	0.000217	0.00329	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—lung cancer	0.000215	0.00326	CbGpPWpGaD
Flunisolide—Malaise—Doxorubicin—lung cancer	0.000215	0.000511	CcSEcCtD
Flunisolide—Vertigo—Doxorubicin—lung cancer	0.000214	0.000509	CcSEcCtD
Flunisolide—Syncope—Doxorubicin—lung cancer	0.000214	0.000508	CcSEcCtD
Flunisolide—Diarrhoea—Docetaxel—lung cancer	0.000213	0.000507	CcSEcCtD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—lung cancer	0.000213	0.00322	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of Androgen receptor activity—SRC—lung cancer	0.000211	0.0032	CbGpPWpGaD
Flunisolide—Palpitations—Doxorubicin—lung cancer	0.000211	0.0005	CcSEcCtD
Flunisolide—NR3C1—Circadian Clock—EP300—lung cancer	0.000211	0.00319	CbGpPWpGaD
Flunisolide—Loss of consciousness—Doxorubicin—lung cancer	0.00021	0.000498	CcSEcCtD
Flunisolide—Cough—Doxorubicin—lung cancer	0.000208	0.000494	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—AVP—lung cancer	0.000208	0.00314	CbGpPWpGaD
Flunisolide—Dizziness—Docetaxel—lung cancer	0.000206	0.00049	CcSEcCtD
Flunisolide—Hypertension—Doxorubicin—lung cancer	0.000206	0.000489	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Methotrexate—lung cancer	0.000205	0.000486	CcSEcCtD
Flunisolide—Insomnia—Methotrexate—lung cancer	0.000203	0.000483	CcSEcCtD
Flunisolide—Myalgia—Doxorubicin—lung cancer	0.000203	0.000482	CcSEcCtD
Flunisolide—Chest pain—Doxorubicin—lung cancer	0.000203	0.000482	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—CXCL8—lung cancer	0.000203	0.00307	CbGpPWpGaD
Flunisolide—Anxiety—Doxorubicin—lung cancer	0.000202	0.00048	CcSEcCtD
Flunisolide—Discomfort—Doxorubicin—lung cancer	0.000201	0.000476	CcSEcCtD
Flunisolide—Dyspnoea—Methotrexate—lung cancer	0.0002	0.000476	CcSEcCtD
Flunisolide—Vomiting—Docetaxel—lung cancer	0.000198	0.000471	CcSEcCtD
Flunisolide—Dyspepsia—Methotrexate—lung cancer	0.000198	0.00047	CcSEcCtD
Flunisolide—Rash—Docetaxel—lung cancer	0.000197	0.000467	CcSEcCtD
Flunisolide—Dermatitis—Docetaxel—lung cancer	0.000197	0.000466	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HES1—lung cancer	0.000196	0.00297	CbGpPWpGaD
Flunisolide—Decreased appetite—Methotrexate—lung cancer	0.000195	0.000464	CcSEcCtD
Flunisolide—Headache—Docetaxel—lung cancer	0.000195	0.000464	CcSEcCtD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL10—lung cancer	0.000195	0.00296	CbGpPWpGaD
Flunisolide—Oedema—Doxorubicin—lung cancer	0.000195	0.000462	CcSEcCtD
Flunisolide—Fatigue—Methotrexate—lung cancer	0.000194	0.00046	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—IL2—lung cancer	0.000194	0.00293	CbGpPWpGaD
Flunisolide—Infection—Doxorubicin—lung cancer	0.000193	0.000459	CcSEcCtD
Flunisolide—Pain—Methotrexate—lung cancer	0.000192	0.000456	CcSEcCtD
Flunisolide—Shock—Doxorubicin—lung cancer	0.000192	0.000455	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MDM2—lung cancer	0.000191	0.00289	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—HIF1A—lung cancer	0.00019	0.00288	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—SKI—lung cancer	0.00019	0.00288	CbGpPWpGaD
Flunisolide—Tachycardia—Doxorubicin—lung cancer	0.00019	0.000451	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—CCND1—lung cancer	0.000189	0.00286	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—JUN—lung cancer	0.000188	0.00285	CbGpPWpGaD
Flunisolide—Hyperhidrosis—Doxorubicin—lung cancer	0.000188	0.000447	CcSEcCtD
Flunisolide—Nausea—Docetaxel—lung cancer	0.000185	0.00044	CcSEcCtD
Flunisolide—Feeling abnormal—Methotrexate—lung cancer	0.000185	0.00044	CcSEcCtD
Flunisolide—Gastrointestinal pain—Methotrexate—lung cancer	0.000184	0.000436	CcSEcCtD
Flunisolide—NR3C1—AP-1 transcription factor network—MMP9—lung cancer	0.000183	0.00278	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—lung cancer	0.000183	0.00277	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—PTEN—lung cancer	0.000182	0.00276	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CAT—lung cancer	0.000182	0.00275	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—lung cancer	0.000181	0.00274	CbGpPWpGaD
Flunisolide—Urticaria—Methotrexate—lung cancer	0.000179	0.000424	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—lung cancer	0.000179	0.0027	CbGpPWpGaD
Flunisolide—Body temperature increased—Methotrexate—lung cancer	0.000178	0.000422	CcSEcCtD
Flunisolide—Abdominal pain—Methotrexate—lung cancer	0.000178	0.000422	CcSEcCtD
Flunisolide—Musculoskeletal discomfort—Doxorubicin—lung cancer	0.000177	0.000421	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CNDP2—lung cancer	0.000177	0.00267	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM2—lung cancer	0.000177	0.00267	CbGpPWpGaD
Flunisolide—Insomnia—Doxorubicin—lung cancer	0.000176	0.000418	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—lung cancer	0.000175	0.00264	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM2—lung cancer	0.000174	0.00264	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—EP300—lung cancer	0.000174	0.00263	CbGpPWpGaD
Flunisolide—Dyspnoea—Doxorubicin—lung cancer	0.000174	0.000412	CcSEcCtD
Flunisolide—Dyspepsia—Doxorubicin—lung cancer	0.000171	0.000407	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL2—lung cancer	0.000171	0.00258	CbGpPWpGaD
Flunisolide—Hydrocortisone—ABCB1—lung cancer	0.00017	0.0156	CrCbGaD
Flunisolide—Decreased appetite—Doxorubicin—lung cancer	0.000169	0.000402	CcSEcCtD
Flunisolide—Fatigue—Doxorubicin—lung cancer	0.000168	0.000398	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—lung cancer	0.000168	0.00254	CbGpPWpGaD
Flunisolide—Constipation—Doxorubicin—lung cancer	0.000166	0.000395	CcSEcCtD
Flunisolide—Pain—Doxorubicin—lung cancer	0.000166	0.000395	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—JUN—lung cancer	0.000166	0.00251	CbGpPWpGaD
Flunisolide—Hypersensitivity—Methotrexate—lung cancer	0.000166	0.000393	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—EIF2B4—lung cancer	0.000165	0.00249	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—HIF1A—lung cancer	0.000165	0.00249	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—CYP1A1—lung cancer	0.000163	0.00246	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—lung cancer	0.000163	0.00246	CbGpPWpGaD
Flunisolide—Asthenia—Methotrexate—lung cancer	0.000161	0.000383	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—lung cancer	0.000161	0.00244	CbGpPWpGaD
Flunisolide—Feeling abnormal—Doxorubicin—lung cancer	0.00016	0.000381	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—CYP2A7—lung cancer	0.00016	0.00242	CbGpPWpGaD
Flunisolide—Gastrointestinal pain—Doxorubicin—lung cancer	0.000159	0.000378	CcSEcCtD
Flunisolide—Pruritus—Methotrexate—lung cancer	0.000159	0.000378	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2A7—lung cancer	0.000157	0.00239	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—RB1—lung cancer	0.000155	0.00235	CbGpPWpGaD
Flunisolide—Urticaria—Doxorubicin—lung cancer	0.000155	0.000367	CcSEcCtD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—lung cancer	0.000155	0.00234	CbGpPWpGaD
Flunisolide—Abdominal pain—Doxorubicin—lung cancer	0.000154	0.000365	CcSEcCtD
Flunisolide—Body temperature increased—Doxorubicin—lung cancer	0.000154	0.000365	CcSEcCtD
Flunisolide—Diarrhoea—Methotrexate—lung cancer	0.000154	0.000365	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—EP300—lung cancer	0.000153	0.00232	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—RARB—lung cancer	0.000153	0.00231	CbGpPWpGaD
Flunisolide—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—lung cancer	0.000152	0.00231	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—MYC—lung cancer	0.000151	0.00229	CbGpPWpGaD
Flunisolide—Dexamethasone—PTGS2—lung cancer	0.000149	0.0136	CrCbGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NPPA—lung cancer	0.000149	0.00225	CbGpPWpGaD
Flunisolide—Dizziness—Methotrexate—lung cancer	0.000149	0.000353	CcSEcCtD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—lung cancer	0.000148	0.00225	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HNRNPA2B1—lung cancer	0.000147	0.00222	CbGpPWpGaD
Flunisolide—Hypersensitivity—Doxorubicin—lung cancer	0.000143	0.00034	CcSEcCtD
Flunisolide—Vomiting—Methotrexate—lung cancer	0.000143	0.000339	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA3—lung cancer	0.000142	0.00216	CbGpPWpGaD
Flunisolide—Rash—Methotrexate—lung cancer	0.000142	0.000336	CcSEcCtD
Flunisolide—Dermatitis—Methotrexate—lung cancer	0.000142	0.000336	CcSEcCtD
Flunisolide—Headache—Methotrexate—lung cancer	0.000141	0.000334	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA3—lung cancer	0.00014	0.00213	CbGpPWpGaD
Flunisolide—Asthenia—Doxorubicin—lung cancer	0.00014	0.000332	CcSEcCtD
Flunisolide—Pruritus—Doxorubicin—lung cancer	0.000138	0.000327	CcSEcCtD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—lung cancer	0.000137	0.00208	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—lung cancer	0.000135	0.00204	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6R—lung cancer	0.000135	0.00204	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CREBBP—lung cancer	0.000134	0.00204	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—KHSRP—lung cancer	0.000134	0.00203	CbGpPWpGaD
Flunisolide—Nausea—Methotrexate—lung cancer	0.000134	0.000317	CcSEcCtD
Flunisolide—Diarrhoea—Doxorubicin—lung cancer	0.000133	0.000316	CcSEcCtD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—lung cancer	0.000132	0.00199	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTA4—lung cancer	0.00013	0.00197	CbGpPWpGaD
Flunisolide—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—lung cancer	0.00013	0.00197	CbGpPWpGaD
Flunisolide—Dizziness—Doxorubicin—lung cancer	0.000129	0.000306	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTA4—lung cancer	0.000128	0.00194	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTA2—lung cancer	0.000127	0.00192	CbGpPWpGaD
Flunisolide—Dexamethasone—ABCB1—lung cancer	0.000127	0.0116	CrCbGaD
Flunisolide—NR3C1—AP-1 transcription factor network—TP53—lung cancer	0.000124	0.00188	CbGpPWpGaD
Flunisolide—Vomiting—Doxorubicin—lung cancer	0.000124	0.000294	CcSEcCtD
Flunisolide—Rash—Doxorubicin—lung cancer	0.000123	0.000291	CcSEcCtD
Flunisolide—Dermatitis—Doxorubicin—lung cancer	0.000123	0.000291	CcSEcCtD
Flunisolide—CYP3A4—Biological oxidations—GSTA1—lung cancer	0.000122	0.00185	CbGpPWpGaD
Flunisolide—Headache—Doxorubicin—lung cancer	0.000122	0.000289	CcSEcCtD
Flunisolide—NR3C1—Gene Expression—EIF2B5—lung cancer	0.000117	0.00178	CbGpPWpGaD
Flunisolide—Nausea—Doxorubicin—lung cancer	0.000116	0.000274	CcSEcCtD
Flunisolide—CYP3A4—Metapathway biotransformation—AKR1C1—lung cancer	0.000116	0.00175	CbGpPWpGaD
Flunisolide—NR3C1—AP-1 transcription factor network—IL6—lung cancer	0.000114	0.00172	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—UGT1A1—lung cancer	0.000114	0.00172	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—NOTCH3—lung cancer	0.000113	0.00171	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—UGT1A1—lung cancer	0.000112	0.0017	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—CDKN1A—lung cancer	0.000111	0.00169	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—TP53—lung cancer	0.00011	0.00166	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—JUNB—lung cancer	0.000107	0.00162	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CXCL8—lung cancer	0.000107	0.00162	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—lung cancer	0.000107	0.00162	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—DICER1—lung cancer	0.000106	0.00161	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—CASP3—lung cancer	0.000102	0.00155	CbGpPWpGaD
Flunisolide—CYP3A4—Tryptophan metabolism—MDM2—lung cancer	0.0001	0.00152	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—IL6—lung cancer	0.0001	0.00152	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—STAT3—lung cancer	9.93e-05	0.0015	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—JUN—lung cancer	9.92e-05	0.0015	CbGpPWpGaD
Flunisolide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—lung cancer	9.81e-05	0.00149	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—HPGDS—lung cancer	9.67e-05	0.00147	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTT1—lung cancer	9.38e-05	0.00142	CbGpPWpGaD
Flunisolide—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—lung cancer	9.34e-05	0.00142	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GCLC—lung cancer	9.27e-05	0.0014	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2A6—lung cancer	9.27e-05	0.0014	CbGpPWpGaD
Flunisolide—NR3C1—Glucocorticoid receptor regulatory network—AKT1—lung cancer	9.25e-05	0.0014	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—SKI—lung cancer	9.16e-05	0.00139	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—EP300—lung cancer	9.15e-05	0.00139	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—VEGFA—lung cancer	8.67e-05	0.00131	CbGpPWpGaD
Flunisolide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—lung cancer	7.95e-05	0.0012	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP2E1—lung cancer	7.89e-05	0.00119	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP2E1—lung cancer	7.78e-05	0.00118	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—RARB—lung cancer	7.35e-05	0.00111	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NPPA—lung cancer	7.17e-05	0.00109	CbGpPWpGaD
Flunisolide—NR3C1—Adipogenesis—IL6—lung cancer	6.94e-05	0.00105	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTP1—lung cancer	6.5e-05	0.000985	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTP1—lung cancer	6.41e-05	0.000971	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—HSPB1—lung cancer	6.16e-05	0.000933	CbGpPWpGaD
Flunisolide—NR3C1—SIDS Susceptibility Pathways—IL6—lung cancer	6e-05	0.000908	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—GSTM1—lung cancer	5.98e-05	0.000905	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—GSTM1—lung cancer	5.89e-05	0.000893	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—CREBBP—lung cancer	5.68e-05	0.00086	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—CYP1A1—lung cancer	5.67e-05	0.000858	CbGpPWpGaD
Flunisolide—CYP3A4—Metapathway biotransformation—CYP1A1—lung cancer	5.59e-05	0.000846	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—NOTCH3—lung cancer	5.43e-05	0.000823	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—JUNB—lung cancer	5.14e-05	0.000779	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—COL4A3BP—lung cancer	4.98e-05	0.000755	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AZIN2—lung cancer	4.98e-05	0.000755	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ATP5H—lung cancer	4.24e-05	0.000642	CbGpPWpGaD
Flunisolide—CYP3A4—Biological oxidations—POMC—lung cancer	4.22e-05	0.00064	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PLBD1—lung cancer	3.78e-05	0.000572	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—ERCC2—lung cancer	3.73e-05	0.000565	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HSD17B10—lung cancer	3.45e-05	0.000523	CbGpPWpGaD
Flunisolide—NR3C1—Generic Transcription Pathway—MYC—lung cancer	3.37e-05	0.00051	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CKB—lung cancer	3.21e-05	0.000486	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM2—lung cancer	3.02e-05	0.000457	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CNDP2—lung cancer	3.02e-05	0.000457	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—MTMR3—lung cancer	2.94e-05	0.000445	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PGAM1—lung cancer	2.86e-05	0.000434	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—CREBBP—lung cancer	2.73e-05	0.000414	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2A7—lung cancer	2.73e-05	0.000414	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—SDC4—lung cancer	2.67e-05	0.000405	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA3—lung cancer	2.43e-05	0.000369	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—RRM1—lung cancer	2.43e-05	0.000369	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—B4GALT5—lung cancer	2.29e-05	0.000347	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA4—lung cancer	2.23e-05	0.000337	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA2—lung cancer	2.17e-05	0.000329	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTA1—lung cancer	2.09e-05	0.000317	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCC3—lung cancer	2.07e-05	0.000313	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKR1C1—lung cancer	2e-05	0.000304	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—UGT1A1—lung cancer	1.95e-05	0.000295	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GNG11—lung cancer	1.88e-05	0.000284	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALDOA—lung cancer	1.79e-05	0.000271	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NCOA3—lung cancer	1.73e-05	0.000263	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ADCY1—lung cancer	1.69e-05	0.000255	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCG2—lung cancer	1.69e-05	0.000255	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MAPK3—lung cancer	1.67e-05	0.000253	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO2—lung cancer	1.65e-05	0.000251	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—HPGDS—lung cancer	1.65e-05	0.000251	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PPP2R1B—lung cancer	1.64e-05	0.000249	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—MYC—lung cancer	1.62e-05	0.000246	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTT1—lung cancer	1.6e-05	0.000243	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2A6—lung cancer	1.59e-05	0.00024	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GCLC—lung cancer	1.59e-05	0.00024	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ENO1—lung cancer	1.5e-05	0.000228	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP2E1—lung cancer	1.35e-05	0.000204	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—NQO1—lung cancer	1.33e-05	0.000202	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—STK11—lung cancer	1.2e-05	0.000182	CbGpPWpGaD
Flunisolide—NR3C1—Gene Expression—AKT1—lung cancer	1.13e-05	0.00017	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTP1—lung cancer	1.11e-05	0.000168	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CAT—lung cancer	1.08e-05	0.000164	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ABCB1—lung cancer	1.05e-05	0.000159	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—TYMS—lung cancer	1.03e-05	0.000157	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—GSTM1—lung cancer	1.02e-05	0.000155	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CYP1A1—lung cancer	9.69e-06	0.000147	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ERCC2—lung cancer	9.61e-06	0.000146	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—APOA1—lung cancer	8.31e-06	0.000126	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CG—lung cancer	7.59e-06	0.000115	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—POMC—lung cancer	7.22e-06	0.000109	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—CREBBP—lung cancer	7.04e-06	0.000107	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CD—lung cancer	6.67e-06	0.000101	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—ALB—lung cancer	6.59e-06	9.97e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CB—lung cancer	5.81e-06	8.81e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTGS2—lung cancer	5.76e-06	8.73e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PTEN—lung cancer	5.02e-06	7.61e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—EP300—lung cancer	4.79e-06	7.26e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—PIK3CA—lung cancer	3.54e-06	5.37e-05	CbGpPWpGaD
Flunisolide—CYP3A4—Metabolism—AKT1—lung cancer	2.9e-06	4.39e-05	CbGpPWpGaD
